Program: 

Maternal-Fetal Medicine

Start Year: 

2026

Why did you choose Duke for your fellowship training?

I ultimately chose to stay at Duke for fellowship because it offered everything I was looking for in a fellowship. During residency I experienced an incredibly supportive culture with mentors who challenged me while genuinely investing in my growth. Clinically, I knew I would receive outstanding training while caring for high-acuity patients. In addition, having built a strong professional and personal community here, it felt like the best place to continue developing into the kind of MFM physician I hope to become. 
 

What excites you about the fellowship program at Duke Obstetrics & Gynecology?

I'm most excited to continue learning from incredible mentors, care for patients with complex pregnancies, and become part of such a supportive and collaborative MFM team. It also feels really special to continue my training at a place that has already felt like home throughout residency! 

What are your career goals?

My goal is to become an academic maternal-fetal medicine physician who provides compassionate, evidence-based care while contributing to research, education, and mentorship

What are your hobbies?

Music! I am classically trained in violin and piano. I also love traveling, trying new restaurants, reading, and spending time with friends and family! 

 

Education & Training

Undergraduate school & graduation year:
Yale University, 2017

Medical school & graduation year:
Yale School of Medicine, 2022

Residency & graduation year:
Duke University School of Medicine, 2026

Awards and Honors

Duke OB/GYN Administrative Chief, 2025-2026
The Parker Prize, Yale School of Medicine, May 2022
David and Harriet Seligson Thesis Prize, Yale School of Medicine, May 2022 
Yale University Commencement Student Marshal, May 2022
Stacy Tessler Lindau Trainee Research Award, 8th annual meeting of Scientific Network on Female Sexual Health and Cancer. November 2021

Publications

Li-Barton JY, Watkins VY, Snow SC, Kuller JA, Federspiel KK. Atrial fibrillation and atrial flutter in pregnancy: epidemiology, pathophysiology, and management.  (2026). Atrial Fibrillation and Atrial Flutter in Pregnancy: Epidemiology, Pathophysiology, and Management. Obstetrical & Gynecological Survey, 81(6), 281–292. https://doi.org/10.1097/OGX.0000000000001538

Schroeder BE, Li-Barton, JY, Howell, J., Baldwin, M., Schaumberg, J., Reynolds, T., Dotters-Katz, S. K. (2025). Effect of longitudinal clerkship model and preceptor continuity on student learning and skills in obstetrics and gynecology. Education for Health, 38(4), 311–320. https://doi.org/10.62694/efh.2025.368

Li-Barton JY, Okunbor J, Sugrue R, Wheeler S, Grace M, Dotters-Katz SK. Outcomes in the immediate subsequent gestation following a pregnancy complicated by previable preterm prelabor rupture of membranes. Pregnancy.

Anastasio MK, Nolin A, Penvose KN, Lambert K, Li JY, Ledbetter L, Davidson BA, Havrilesky LJ, Albright BB. Adjuvant therapy and recurrence risk in non-myoinvasive high-grade (stage IC) endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol. 2024 Sep 19;191:10-18. doi: 10.1016/j.ygyno.2024.09.011. Epub ahead of print. PMID: 39305819.

Hathout L, Sherwani ZK, Alegun J, Ohri N, Fields EC, Shah S, Beriwal S, Horne ZD, Kidd EA, Leung EW, Song J, Taunk NK, Chino J, Huang C, Russo AL, Dyer M, Li JY, Albuquerque KV, Damast S. Prognostic Effect of Mismatch Repair Status in Early-Stage Endometrial Cancer Treated With Adjuvant Radiation: A Multi-institutional Analysis. Int J Radiat Oncol Biol Phys. 2024 Jul 15;119(4):1158-1165. doi: 10.1016/j.ijrobp.2024.01.203. Epub 2024 Jan 20. PMID: 38253292.

Li JY, Tien CJ, Kassick M, Peters G, Damast S. Investigating the efficacy of simulation-based education for interstitial gynecologic brachytherapy using a novel US/MR/CT-compatible gynecologic phantom. Brachytherapy. 2023 Mar-Apr;22(2):157-165. doi: 10.1016/j.brachy.2022.11.006. Epub 2022 Dec 15. PMID: 36528476.

Patrich T, Wang Y, Elshaikh MA, Zhu S, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Taunk NK, Chino J, Russo AL, Lea JS, Lee LJ, Albuquerque KV, Hathout L. The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis. Am J Clin Oncol. 2023 Mar 1;46(3):114-120. doi: 10.1097/COC.0000000000000975. Epub 2023 Jan 10. Erratum in: Am J Clin Oncol. 2023 Jun 01;46(6):279. doi: 10.1097/COC.0000000000001008. PMID: 36625449.

Li JY, Huang GS. ARID1A Deficiency as a Biomarker for Sensitivity to Ionizing Radiation and ATR Inhibition in Gynecologic Malignancies. Yale University ProQuest Dissertations & Theses, 2022. 28971391.

Li JY, Park HS, Huang GS, Young MR, Ratner E, Santin A, Damast S. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy. Gynecol Oncol. 2021 Dec;163(3):557-562. doi: 10.1016/j.ygyno.2021.09.018. Epub 2021 Oct 1. PMID: 34602287.

Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep. 2021 Dec 20;39:100913. doi: 10.1016/j.gore.2021.100913. PMID: 35005157.

Li JY, Arkfeld CK, Tymon-Rosario J, Webster E, Schwartz P, Damast S, Menderes G. An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. J Gynecol Oncol. 2021 Nov 30. doi: 10.3802/jgo.2022.33.e13. Epub ahead of print. PMID: 34910394.

Yoon J, Fitzgerald H, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ, Hathout L. Does prophylactic para-aortic lymphatic irradiation improve outcomes in women with stage IIIC1 endometrial carcinoma? A multi-institutional pooled analysis. Pract Radiat Oncol. 2021 Nov 22:S1879-8500(21)00280-0. doi: 10.1016/j.prro.2021.10.002. Epub ahead of print. PMID: 34822999.

Li JY, D'Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S. Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy. Am J Clin Oncol. 2021 Apr 1;44(4):143-149. doi: 10.1097/COC.0000000000000800. PMID: 33755031.

Hathout L, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1423-1431. doi: 10.1016/j.ijrobp.2021.02.055. Epub 2021 Mar 5. PMID: 33677053.

Diamond BH, Jairam V, Zuberi S, Li JY, Marquis TJ, Rutter CE, Park HS. Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases under 3 cm: A multi-institutional retrospective analysis. J Radiosurg SBRT. 2021;7(3):179-187. PMID: 33898081

Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S. Stage III uterine serous carcinoma: modern trends in multimodality treatment. J Gynecol Oncol. 2020 Jul;31(4):e53. doi: 10.3802/jgo.2020.31.e53. Epub 2020 Feb 17. PMID: 32266802; PMCID: PMC7286763.

Ortega J, Li JY, Lee S, Tong D, Gu L, Li GM. Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis. Proc Natl Acad Sci U S A. 2015 May 5;112(18):5667-72. doi: 10.1073/pnas.1417711112. Epub 2015 Mar 30. PMID: 25825764; PMCID: PMC4426468.

Ortega J, Li J, Ensor M, Gu L. PCNA tyrosine phosphorylation by EGFR promotes genome instability. The FASEB Journal. 2013 Apr 1; 27 (S1): 542.6-542.6.

Presentations

Li JY, Hofler L, Chapman C, Grace M, Dotters-Katz S. “Applying to OBGYN Fellowships as DO: What are the odds?” Accepted for oral presentation at 2025 CREOG & APGO. Philadelphia, PA. Feb 2025.

Li JY, Tien CJ, Kassick M, Peters G, Damast S. “Investigating the efficacy of simulation-based education for interstitial gynecologic brachytherapy using a novel US/MR/CT-compatible gynecologic phantom.” Accepted for oral presentation at the American Brachytherapy Society Annual Meeting. Denver, CO. Jun 2022.

Li JY, Park H, Huang G, Young MR, Ratner E, Santin A, Damast S. “Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.” Accepted for oral presentation at the 63^rd American Society for Radiation Oncology, Chicago, IL. Oct 2021.

Li JY, D'Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S. “Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.” Accepted for oral presentation at 8^th annual meeting of Scientific Network on Female Sexual Health and Cancer. November 2021. Awarded the 2021 Stacy Tessler Lindau Trainee Research Award 

Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz P, Damast S. “Stage III Uterine Serous Carcinoma: Improved Outcomes in the Modern Era with Multi-Modality Treatment.” Accepted for oral presentation at 61^st American Society for Radiation Oncology, Chicago, IL. Sept 2019. Selected for Best of ASTRO 2019, Washington DC, Nov. 2019. 

Li JY, Howell J, Baldwin M, Dotters-Katz S. “Impact of Longitudinal OBGYN Clinic on Student Hands-On Experience.” Accepted for poster presentation at 2025 CREOG & APGO. Philadelphia, PA. Feb 2025.

Patrich T, Wang Y, Elshaikh M, Zhu S, Damast S, Li JY, Fields E, Beriwal S, Keller A, Kidd E, Usoz M, Jolly S, Jaworski E, Leung E, Donovan E, Taunk N, Chino J, Russo A, Lea J, Lee L, Albuquerque K, Hathout L. “Racial Disparities in Patients with Stage IIIC Endometrial Cancer.” Accepted for poster presentation at the 64^th American Society for Radiation Oncology, San Antonio, TX. Oct 2022.

Li JY, Li Z, Ji J, Soble W, Baro M, Lee H, Damast S, Contessa J, Huang G. “ARID1A deficiency as a biomarker for sensitivity to radiation and ATR inhibition.” Accepted for poster presentation at Society of Gynecologic Oncology 2022 Annual Meeting on Women’s Cancer, Phoenix, AZ. March 2022.

Ji J, Li Z, Sherman E, Osagie O, Mi S, Soble W, Li JY, Huang G. “Evaluation of ATR inhibitors for targeted therapy of ovarian clear cell carcinoma.” Accepted for oral presentation at Society of Reproductive Investigation 68^th Annual Meeting. Jul 2021.

Li JY, Mutlu L, Tymon-Rosario J, Hui P, Menderes G. “Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites.” Accepted for presentation at Society of Gynecologic Oncology 2021 Annual Meeting on Women’s Cancer, Chicago, IL. Mar 2021. 

Hathout L, Wang Yaqun, Elshaikh M, Dimitrova I, Damast S, Li JY, Fields E, Beriwal S, Keller A, Kidd E, Usoz M, Jolly S, Jaworski E, Leung E, Donovan E, Taunk N, Russo A, Jayanthi L, Alburquerque K, Lee L. “Does sequencing of adjuvant therapy influence outcome for stage IIIC endometrial carcinoma? A multi-institutional analysis.” Accepted for oral presentation at 62^nd American Society for Radiation Oncology Annual Meeting, Miami, FL. Oct 2020. 

Research Interests

Some of my research interests include placenta accreta spectrum, cardio-obstetrics, and medical education. I'm excited to pursue research that helps answer clinically relevant questions and improves the care we provide to patients with high-risk pregnancies.